Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Jul;50(1):77–83. doi: 10.1038/bjc.1984.141

Identification of a subpopulation of MeCCNU resistant cells in previously untreated Lewis lung tumours.

T C Stephens, K Adams, J H Peacock
PMCID: PMC1976914  PMID: 6743517

Abstract

A variety of experimental endpoints including excision cell survival, lung colony curability, tumour regrowth delay and i.m. tumour curability following MeCCNU alone and combined with gamma-radiation, were used to define the MeCCNU cell survival curve down to "tumour cure" level in previously untreated i.m. Lewis lung tumours. The survival curve was found to be biphasic, the tumour cells being markedly resistant to MeCCNU at high doses of the drug. Below 10 mg kg-1 the survival curve was exponential through the origin with a D10 of approximately 2 mg kg-1, while above 15 mg kg-1 the D10 was approximately 25 mg kg-1. From linear extrapolation of the terminal part of the cell survival curve to zero drug dose, it appeared that about 1 in 10(5) (or 0.001%) of tumour cells were resistant to MeCCNU.

Full text

PDF
77

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blackett N. M., Courtenay V. D., Mayer S. M. Differential sensitivity of colony-forming cells of hemopoietic tissue, Lewis lung carcinoma, and B16 melanoma to three nitrosoureas. Cancer Chemother Rep. 1975 Sep-Oct;59(5):929–933. [PubMed] [Google Scholar]
  2. Courtenay V. D. A soft agar colony assay for Lewis lung tumour and B16 melanoma taken directly from the mouse. Br J Cancer. 1976 Jul;34(1):39–45. doi: 10.1038/bjc.1976.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Mayo J. G., Laster W. R., Jr, Andrews C. M., Schabel F. M., Jr Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy. Cancer Chemother Rep. 1972 Apr;56(2):183–195. [PubMed] [Google Scholar]
  4. Mulcahy R. T. Chemical properties of nitrosoureas: implications for interaction with misonidazole. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):599–602. doi: 10.1016/0360-3016(82)90692-7. [DOI] [PubMed] [Google Scholar]
  5. Mulcahy R. T., Siemann D. W., Sutherland R. M. Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut. Br J Cancer. 1982 Jun;45(6):835–842. doi: 10.1038/bjc.1982.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Schabel F. M., Jr Nitrosoureas: a review of experimental antitumor activity. Cancer Treat Rep. 1976 Jun;60(6):665–698. [PubMed] [Google Scholar]
  7. Shipley W. U., Peacock J. H., Steel G. G., Stephens T. C. Continuous irradiation of the Lewis lung carcinoma in vivo at clinically-used "ultra" low-dose-rates. Int J Radiat Oncol Biol Phys. 1983 Nov;9(11):1647–1653. doi: 10.1016/0360-3016(83)90418-2. [DOI] [PubMed] [Google Scholar]
  8. Steel G. G., Adams K. Enhancement by cytotoxic agents of artificial pulmonary metastasis. Br J Cancer. 1977 Dec;36(6):653–658. doi: 10.1038/bjc.1977.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Steel G. G., Adams K. Stem-cell survival and tumor control in the Lewis lung carcinoma. Cancer Res. 1975 Jun;35(6):1530–1535. [PubMed] [Google Scholar]
  10. Steel G. G., Hill R. P., Peckham M. J. Combined radiotherapy--chemotherapy of Lewis lung carcinoma. Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):49–52. doi: 10.1016/0360-3016(78)90114-1. [DOI] [PubMed] [Google Scholar]
  11. Stephens T. C., Currie G. A., Peacock J. H. Repopulation of gamma-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors. Br J Cancer. 1978 Nov;38(5):573–582. doi: 10.1038/bjc.1978.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Stephens T. C., Peacock J. H. Cell yield and cell survival following chemotherapy of the B16 melanoma. Br J Cancer. 1978 Nov;38(5):591–598. doi: 10.1038/bjc.1978.254. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES